Dofuse 50 MG Injection 1 ML is used for the short-term management of heart failure and cardiac decompensation, particularly when the heart muscles are weakened and unable to pump blood effectively. It belongs to a class of medications known as inotropic agents, which are designed to enhance cardiac contractility and improve heart function in critical care settings.
This medicine is also used during open-heart surgical procedures where temporary cardiac support is necessary. Additionally, it serves as a valuable therapeutic option in managing various heart diseases and shock states where enhanced cardiac output is essential. The injection also has a unique diagnostic application as an alternative to exercise stress testing for evaluating cardiac function in patients unable to perform physical exercise.
The medicine must be administered exclusively in hospital or clinical settings by qualified healthcare professionals. You should inform your doctor about any pre-existing conditions or ongoing medications before this medicine is administered. If you notice any side effects during administration, notify your doctor immediately. The medicine will be administered for the shortest time necessary to achieve hemodynamic stability as determined by your doctor.























































